- Future Students
- Current Students
- Faculty & Staff
Filters: Author is Kolonoski, P [Clear All Filters]
Bermudez LE, Kolonoski P, Young LS, Inderlied CB. 1994. Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.. Antimicrobial agents and chemotherapy. 38(8):1844-8.
Bermudez LE, Inderlied CB, Kolonoski P, Petrofsky M, Young LS. 1994. Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.. Antimicrobial agents and chemotherapy. 38(12):2717-21.
Bermudez LE, Inderlied CB, Kolonoski P, Wu M, Aralar P, Young LS. 2001. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.. Antimicrobial agents and chemotherapy. 45(8):2210-4.
Bermudez LE, Inderlied CB, Kolonoski P, Wu M, Barbara-Burnham L, Young LS. 1996. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.. Antimicrobial agents and chemotherapy. 40(3):546-51.
Bermudez LE, Martinelli J, Petrofsky M, Kolonoski P, Young LS. 1994. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model.. The Journal of infectious diseases. 169(3):575-80.
Bermudez LE, Stevens P, Kolonoski P, Wu M, Young LS. 1989. Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor.. Journal of immunology (Baltimore, Md. : 1950). 143(9):2996-3000.